A1RG34:BVMF
Argenx Se Bdr
R$208.00
arrow_downward
-1.74%(-3.68) 1D
Sep 8, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$208.00
High
R$208.00
Low
R$208.00
Mkt. cap
61.57B
Avg. vol.
59.00
Volume
3.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
Open
R$208.00
High
R$208.00
Low
R$208.00
Mkt. cap
61.57B
Avg. vol.
59.00
Volume
3.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
Investing.com
·
7 hours ago
argenx at wells fargo healthcare conference: broadening beyond vyvgart
AD HOC NEWS
·
1 day ago
Argenx stock holds firm as biotech investors weigh recent clinical progress
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr